GentiBio Names Dr. Mark Bach as Chief Medical Officer
30 Sep 2024 //
CONTRACT PHARMA
BMS Bets up to $1.9 Billion on GentiBio’s Treg Platform for IBD
11 Aug 2022 //
BIOPHARMADIVE
GentiBio Appoints Neely Mozaffarian, MD, PhD as Chief Medical Officer
01 Jun 2022 //
PRNEWSWIRE